Cantabio Pharmaceuticals Awarded Grant From The Michael J. Fox Foundation to Develop Novel Small-Molecule Aggregation Inhibitors of the Tau Protein for the Treatment of Parkinson’s Disease
Accesswire
*Grant enables the further development of Cantabio's novel small-molecule tau protein aggregation inhibitors, which have high..
